Does 5mg of Mounjaro actually work for weight loss?

What is 5mg actually doing in your body?

Mounjaro is a dual GIP and GLP-1 receptor agonist, the only weight-loss medicine licensed in the UK that activates both of those gut-hormone pathways at once. At 2.5mg, those receptors are engaged, but the dose is calibrated to get your digestive system used to the medicine rather than to drive significant weight change. If you have questions about whether 2.5mg Mounjaro is actually working, it helps to understand that this starting dose is designed for tolerability, not treatment. When your prescriber moves you to 5mg, you cross into the range where appetite suppression and slowed gastric emptying are working properly. Most people notice food feels satisfying much sooner, hunger between meals quietens, and the pull toward high-calorie choices weakens.

The NHS medicines page for tirzepatide confirms that the treatment schedule starts at 2.5mg for tolerability before stepping up, with 5mg as the next stage. That structure matters: the 2.5mg pen's job is adjustment, not treatment. By the time you reach 5mg, the medicine is doing what it was prescribed for.

One simple thing worth doing: check the date on your current pen before every injection. Mounjaro must be stored refrigerated between 2°C and 8°C, and the patient information leaflet specifies a limited window once it has been out of the fridge, a 30-second check that protects the medicine's potency.

How much weight loss can 5mg realistically produce?

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults with obesity and tested tirzepatide at 5mg, 10mg and 15mg against placebo over 72 weeks. The 5mg group achieved an average body-weight reduction of around 15%, roughly three times the result seen in the placebo group. That is a clinically significant result in its own right, even before considering whether a higher dose might suit you better over time.

The evidence also shows a dose-response relationship: 10mg and 15mg produced progressively greater average losses (around 20% at the highest dose). So 5mg sits at the lower end of the therapeutic range rather than the top, your prescriber will discuss whether stepping up makes sense for you, based on your progress and how you are tolerating the current dose. If you are curious about how long 5mg takes to produce visible changes, that timeline varies but most people report noticeable differences within the first four weeks on this dose.

It is also worth reading about what clinicians mean by the 'golden dose', the idea that there is a sweet spot where weight loss is strong and side effects are well managed, which differs from person to person.

What side effects are most common at 5mg?

The side-effect profile at 5mg mirrors the programme overall. Gastrointestinal effects are the most frequently reported: nausea, loose stools or constipation, indigestion, and burping. For most people these peak shortly after the dose increase and ease within one to two weeks as the body adapts. Fatigue and mild headaches are also noted in trials, particularly in the early weeks at a new dose level.

More serious but less frequent effects include pancreatitis. In January 2026 the MHRA issued a Drug Safety Update specifically covering GLP-1 medicines, noting that acute pancreatitis is a known if infrequent risk: seek urgent medical attention for severe stomach pain that radiates to the back, with or without vomiting. If you experience any symptoms that concern you, contact a clinician promptly rather than waiting for your next scheduled review. You can also report suspected side effects directly to the MHRA through the Yellow Card scheme.

The question of whether 2.5 Mounjaro is doing enough is one our prescribers hear regularly, and the honest answer is that some people feel a noticeable step up when moving to 5mg, while others barely register the change. Eating smaller portions and avoiding very fatty meals helps considerably.

Should you stay at 5mg or move higher?

This is genuinely a clinical decision, not a personal preference call. Your prescriber will look at how much weight you have lost over the weeks on 5mg, how well you are tolerating the dose, and what your treatment goals are. NICE's appraisal of tirzepatide (TA1026) notes that if less than 5% weight loss is achieved after six months at the highest tolerated dose, continuing treatment should be reviewed, giving a clear clinical benchmark for what 'working' means at a population level.

Some people do stay at 5mg for an extended period, either because they are achieving good results or because they prefer to avoid stepping higher. Others move through the dose schedule more quickly. There is no single right answer. What matters is that the decision is made with a prescriber who has seen your progress data, not based on what worked for someone else. The Mounjaro 5mg overview covers the dose in more detail, and if you are thinking about the longer journey, the broader Mounjaro treatment guide sets out what the full schedule looks like from start to finish.

Private treatment through a regulated service means you are not waiting months to have that conversation. At nume, a GPhC-registered prescriber reviews every consultation personally, your answers go to a clinician's desk, not through an algorithm. If you want to discuss your current dose or explore whether 5mg is the right place to be, speak to our prescribers through a free consultation.